Dexcom, Inc.

Other

John Michael Gray

Peter C Simpson

Jason M Halac

Jennifer Blackwell

Kenneth Pirondini

Paul V Neale

Maria Noel Brown Wells

Justen Deering England

David A Keller

Mark Douglas Kempkey

Neel Narayan Shah

Andrew Michael Reinhardt

John Charles Barry

Neal Davis Johnston

Randall Scott Koplin

Young Woo Lee

Warren Marc Terry

Patrick John Castagna

Andrew C Joncich

Apurv Ullas Kamath

Ryan Everett Schoonmaker

Alan Baldwin

Ted Tang Lee

Jason Mitchell

David DeRenzy

Thomas Metzmaker

Carol Wood Sutherland

Louise Emma Van Den Heuvel

Cameron Brock

Christian Michael Andre George

Daniel E Apacible

Jason C Wong

Remy E Gagnon

Sumitaka Mikami

Philip Thomas Pupa

Michael Robert Mensinger

Eli Reihman

Katherine Yerre Koehler

Hari Hampapuram

Rian W Draeger

Arturo Garcia

Scott M Belliveau

Jeff Jackson

Becky L Clark

Chris W Dring

David Rego

Kyle Thomas Stewart

Matthew Lawrence Johnson

Craig Thomas Gadd

John Stanley Hayes

Kris Elliot Higley

Subrai Girish Pai

Timothy Joseph Goldsmith

Carl Erich Hoffmeier

Sean T Saint

Eric Cohen

Leif N Bowman

Brian Christopher Smith

Sebastian Bohm

Naresh Chandra Bhavaraju

Phil Mayou

Paul D Kramer

Esteban Cabrera, Jr

Anna Leigh Davis

Aditya Sagar Mandapaka

Andrew Attila Pal

Gary A Morris

Nicholas Polytaridis

Paul Noble-Campbell

Lauren Hruby Jepson

Alexandra Elena Constantin

Disha B Sheth

Atiim Joseph Wiley

Todd Andrew Newhouse

Tomas C Walker

Basab Dattaray

Andrea Jean Jackson

Nathaniel David Heintzman

Shanger Wang

Minglian Shi

Nicholas Kalfas

Patrick Wile McBride

Joseph J Baker

Jiong Zou

Michael Levozier Moore

Daniel Justin Wiedeback

Margaret A Crawford

Lauren Danielle Armenta

Hemant Mahendra Nirmal

John Patrick Majewski

Leah Morta Edra

Shawn Clay Sanders

Matthew T Vogel

Nirav Bhatt

Jonathan Bodnar

Douglas William Burnette

Michael A Ploof

Liang Wang

Daud Abd Al-Malik Zoss

Justin E Cuzens

Certain embodiments herein relate to a physiological parameter monitoring system. The system may include a sensor and sensor electronics connectable to the sensor. The system may also include a transmitter operably connected to the sensor electronics, the transmitter having or being configured to have at least a portion thereof positioned at a first location adjacent to and/or in contact with an external surface of a body of a host during a sensor session, the transmitter further configured to wirelessly transmit sensor information using human body communication. The system may further include a first display device comprising a display and a receiver, the receiver having or being configured to have at least a portion thereof positioned at a second location adjacent to and/or in contact with the external surface of the body during the sensor session, the receiver further configured to receive sensor information from the transmitter using human body communication.

Network physical layer configurations for ambulatory physiological parameter monitoring and therapeutic intervention systems

An analyte sensor system is provided. The system includes a base configured to attach to a skin of a host. The base includes an analyte sensor configured to generate a sensor signal indicative of an analyte concentration level of the host, a battery, and a first plurality of contacts. The system includes a sensor electronics module configured to releasably couple to the base. The sensor electronics module includes a second plurality of contacts, each configured to make electrical contact with a respective one of the first plurality of contacts, and a wireless transceiver configured to transmit a wireless signal based at least in part on the sensor signal. The system includes a first sealing member configured to provide a seal around the first and second plurality of contacts within a first cavity. Related analyte sensor systems, analyte sensor base assemblies and methods are also provided.

Systems and methods relating to an analyte sensor system having a battery located within a disposable base

Systems for applying a transcutaneous monitor to a person can include a telescoping assembly, a sensor, and a base with adhesive to couple the sensor to skin. The sensor can be located within the telescoping assembly while the base protrudes from a distal end of the system. The system can be configured to couple the sensor to the base by compressing the telescoping assembly.

Transcutaneous analyte sensor systems and methods

Systems and methods are provided to determine a time to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a model or pattern. The time to deliver guidance may be calculated to be useful to a user in the management of a glucose concentration level.

System and method for providing personalized guidance to diabetes patients

Pre-connected analyte sensors are provided. A pre-connected analyte sensor includes a sensor carrier attached to an analyte sensor. The sensor carrier includes a substrate configured for mechanical coupling of the sensor to testing, calibration, or wearable equipment. The sensor carrier also includes conductive contacts for electrically coupling sensor electrodes to the testing, calibration, or wearable equipment.

Pre-connected analyte sensors

Various examples are directed to systems and methods for measuring a parameter related to patient health. An analyte sensor system may detect that the analyte sensor system has been applied to a host and may store analyte data describing the host. The analyte sensor system may determine that sensor use at the analyte sensor system has terminated and upload stored analyte data to an upload computing device.

Intermittent monitoring

Various examples are directed to systems and methods for patient monitoring. An example method comprises receiving an estimated glucose concentration level of the patient from a continuous glucose monitoring (CGM) system for a first time period. The method may also include receiving non-glucose information relating to the patient for the first time period and determining a relationship between the estimated glucose concentration level and the non-glucose information. The method may also include receiving non-glucose information relating to the patient for a second time period and determining diabetic information about the patient for the second time period based upon the determined relationship and the non-glucose information. The method may include electronically delivering a notification about the diabetic information.

Sensor systems can be used to measure an analyte concentration. Sensor systems can include a base having a distal side configured to face towards a person's skin. An adhesive can couple the base to the skin. A transcutaneous analyte measurement sensor can be coupled to the base and can be located at least partially in the host. A transmitter can be coupled to the base and can transmit analyte measurement data to a remote device.

Disclosed are systems and methods for generating graphical displays of analyte data and/or health information. In some implementations, the graphical displays are generating based on a self-referential dataset that are modifiable based on identified portions of the data. The modified graphical displays can indicate features in the analyte data of a host.

Systems and methods for health data visualization and user support tools for continuous glucose monitoring

Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.

System and method for decision support

Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration data sensed by a glucose concentration sensor. A host state change associated with the host glucose concentration data may be determined. A guidance message based at least in part on the host state change may also be determined. The guidance message may be delivered through a user interface.

Growing community of inventors

San Diego, CA, United States of America

John Michael Gray